HISTOGENICS CORP (HSGX)
Institutional ownership reported to the SEC as of Q2 2022, across 15 quarters.
1
Reporting holders
$16.0K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Abingworth LLP | $16.0K | 7,111 | 0.01% | 15q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2022 | 1 | $16.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $23.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q4 2021 | 1 | $32.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q3 2021 | 1 | $51.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q2 2021 | 1 | $57.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q1 2021 | 1 | $48.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q4 2020 | 1 | $13.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q3 2020 | 1 | $2.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q2 2020 | 1 | $2.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q1 2020 | 1 | $2.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q4 2019 | 1 | $4.0K | 7,111 | 0 | 0 | 0 | 0.0% |
| Q3 2019 | 1 | $20.0K | 7,111 | 0 | 0 | 1 | 0.0% |
| Q2 2019 | 19 | $7.3M | 38,116,037 | 4 | 3 | 6 | 0.0% |
| Q1 2019 | 19 | $1.2M | 10,525,872 | 3 | 5 | 6 | 0.0% |
| Q4 2018 | 24 | $984.0K | 10,014,253 | 2 | 0 | 0 | 10.4% |